Accumulating evidence suggests that microRNAs (miRNAs) are important gene regulators, which can have critical roles in diverse biological processes including tumorigenesis. In this study, we analyzed the miRNA expression profiles in non-small cell lung carcinoma (NSCLC) by use of a miRNA microarray platform and identified 40 differentially expressed miRNAs. We showed that miRNA (miR)-451 was the most downregulated in NSCLC tissues. The expression level of miR-451 was found to be significantly correlated with tumor differentiation, pathological stage and lymph-node metastasis. Moreover, low miR-451 expression level was also correlated with shorter overall survival of NSCLC patients (Po0.001). Ectopic miR-451 expression significantly suppressed the in vitro proliferation and colony formation of NSCLC cells and the development of tumors in nude mice by enhancing apoptosis, which might be associated with inactivation of Akt signaling pathway. Interestingly, ectopic miR-451 expression could significantly inhibit RAB14 protein expression and decrease a luciferasereporter activity containing the RAB14 3 0 -untranslated region (UTR). In addition,, RNA interference silencing of RAB14 gene could recapitulate the tumor suppressor function of miR-451, whereas restoration of RAB14 expression could partially attenuate the tumor suppressor function of miR-451 in NSCLC cells. Furthermore, we also showed that strong positive immunoreactivity of RAB14 protein was significantly associated with downregulation of miR-451 (P ¼ 0.01). These findings suggest that miR-451 regulates survival of NSCLC cells partially through the downregulation of RAB14. Therefore, targeting with the miR-451/RAB14 interaction might serve as a novel therapeutic application to treat NSCLC patients.
Introduction
Lung cancer is the most frequent cause of cancer-related death both in China and in many other countries. Non-small cell lung carcinoma (NSCLC) accounts for 70-80% of lung cancer diagnoses and the disease is generally diagnosed at an advanced stage (Jemal et al., 2008) . Despite advances made in clinical treatment, the prognosis of NSCLC patients, especially with advanced disease is still very poor. Lung carcinogenesis is a multistep process, which results from activation of oncogenes and inactivation of tumor suppressor genes (Minna et al., 2002) . Up to date, the molecular mechanisms underlying the development of NSCLC are still poorly understood. Therefore, a better understanding of the molecular mechanisms involved in NSCLC formation and development will be helpful to develop novel therapeutic targets and strategies for the treatment of human NSCLC.
MicroRNAs (miRNA) are small (B20B22 nucleotides) non-coding RNAs that bind to partially complementary recognition sequences of mRNA, causing either degradation or inhibition of translation, thus effectively silencing their mRNA target (Behm-Ansmant et al., 2006) . Generally, one gene can be repressed by multiple miRNAs and one miRNA may repress multiple target genes, which results in the formation of complex regulatory feedback networks (Chaudhuri and Chatterjee, 2007) . By these molecular mechanisms, miRNAs have been reported to be involved in specific cellular processes such as differentiation, morphogenesis and tumorigenesis (Skaftnesmo et al., 2007; Gordeladze et al., 2009; Wu et al., 2009) . Many reports have pointed to a role for miRNAs in the etiology and pathogenesis of cancer by targeting oncogenes or tumor suppressors (Zhang et al., 2007; Shenouda and Alahari, 2009) . Although the global alteration of miRNA expression becomes a hallmark of tumorigenesis, the researches addressing the roles of miRNAs in cellular transformation and tumorigenesis are still at an early stage. In particular, the genes targeted by most of these miRNAs are unknown. Thus, the identification of the target of miRNAs would be critical to understand the characterization of the miRNA pathways and their underlying molecular mechanisms associated with NSCLC progression and development.
In this study, we investigated miRNA expression profiles in specimens from patients with NSCLC and identified a set of differentially expressed miRNAs. Meanwhile, miRNA-451, one of the most downregulated miRNAs identified in this study, was further explored for its functions in NSCLC cells. Moreover, the direct inhibition of Ras-related protein 14 (RAB14) translation by miR-451 and the potential involvement of miR-451 as a growth suppressor in NSCLC cells have been experimentally testified.
Results

Identification of aberrant miRNAs expression in NSCLC tissue samples
To identify miRNAs, which were differentially expressed between NSCLC and corresponding non-tumor lung tissues, miRNA microarray analysis was performed (Supplementary Figure S1) . The differentially expressed miRNAs with at least a fivefold change in expression were shown (Supplementary Table S1 ). A total of 27 miRNAs were upregulated and 13 miRNAs were downregulated in NSCLC tissue samples. Of these miRNAs, miR-451 showed the largest degree of downregulation (170.9-fold), whereas miR-196a showed the largest degree of upregulation (101.8-fold).
Validation of miRNA microarray data by real-time quantitative reverse transcription-PCR (qRT-PCR)
To validate the miRNA microarray data, we used Taqman MicroRNA Assay Kit (Applied Biosystems, Foster City, CA, USA) to perform real-time quantitative reverse transcription (qRT-PCR) analyses of the expression levels of six miRNAs (miR-451, 196a, 335*, 30a, 205 and 126) in NSCLC tumor and corresponding non-tumor lung tissues. To validate the presumed stable expression of a given control gene, the expression values were normalized to U6 RNA levels. As compared with non-tumor tissues, three miRNAs (miR-451, 30a and 126) were significantly downregulated in NSCLC tissues, whereas other four miRNAs (miR-196a, 335* and 205) were significantly upregulated in non-tumor lung tissues (Po0.01). The qRT-PCR analysis showed similar patterns of up or downregulation to those shown in the results of microarray analysis (Figure 1 ). However, the magnitude of the fold changes in expression differed somewhat between what was shown in microarray analysis and what was shown in qRT-PCR analysis.
Decreased miR-451 expression in NSCLC tissues was correlated with poor tumor differentiation, advanced pathological stage, lymph node metastasis and poor prognosis MiR-451 could be observed to be significantly downregulated in NSCLC tissues compared with that in corresponding non-tumor lung tissues. The clinicopathological characteristics of 23 NSCLC patients were shown (Supplementary Table S2 ). Among 23 matched normal and NSCLC tumor tissues, miR-451 was significantly downregulated in 20 cancer tissues compared with the corresponding non-tumor lung tissues (Figure 2a) . Moreover, we also examined the correlation of miR-451 expression with the clinicopathological factors (Figures 2b-d) . The miR-451 downregulation was correlated with poor tumor differentiation (P ¼ 0.0035), advanced pathological stage (P ¼ 0.007) and lymph-node metastasis (P ¼ 0.0026). Kaplan-Meier survival analysis and log-rank test by using patient Figure 1 Validation of microarray analysis data. The relative expression levels of six dysregulated miRNAs (miR-451, 196a , 335*, miR-205, 30a and 126) were determined by qRT-PCR. U6 was used as an internal control. Each qRT-PCR experiment was performed in triplicate. **Po0.01. Normal: non-tumor lung tissues.
MicroRNA-451 functions as a tumor suppressor in human NSCLC R Wang et al postoperative survival was performed to further evaluate the correlation between miR-451 expression and prognosis of NSCLC patient. According to the median ratio of relative miR-451 expression (83.4) in tumor tissues, the 23 NSCLC patients were classified into two groups: High-miR-451 group (n ¼ 10): miR-451 expression ratioXmedian ratio; Low-miR-451 group (n ¼ 13): miR-451 expression ratioomean ratio. From KaplanMeier survival curve, we observed that patients with high miR-451 expression (n ¼ 10) had significant longer survival than those with low miR-451 expression (n ¼ 13) (Po0.001, log-rank test; Figure 3 ). Thus, it was concluded that downregulation of miR-451 expression might have important roles in NSCLC progression and development.
Downregulation of miR-451 was associated with DNA methylation or histone deacetylation To determine whether miR-451 was a putative tumor suppressor in NSCLC, real-time qRT-PCR analysis was performed to detect the expression levels of miR-451 in three NSCLC cell lines (A549, SPC-A1 and NCI-H450) and a normal human bronchial epithelial cell line (16HBE). As shown in Figure 4a , the expression levels of endogenous miR-451 in NSCLC cell lines were significantly lower compared with the normal bronchial epithelial cell line and the expression levels of miR-451 showed variable among NSCLC cell lines. As there have been no few reports about genomic loss or mutations at 17q11 where miR-451 was located in NSCLC, we want to investigate whether downregulation of miR-451 in NSCLC cells was associated with epigenetic mechanisms including DNA methylation or histone deacetylation. After SPC-A1 cell line was treated with a DNA methylating agent (5-aza-dC) and/or a histone deacetylase inhibitor (PB), the status of miR-451 expression was determined ( Figure 4b ). Compared with SPC-A1 cells with no treatment, the relative levels of miR-451 expression were significantly increased by 2.5, 4.2 or 6.4-folds in SPC-A1 cells with 5-aza-dC, PB or both treatment. These data showed that DNA methylation or histone deacetylation might be involved in the downregulation of miR-451 in NSCLC cells, but the exact mechnisms needs to be further elucidated. Effects of miR-451 expression on in vitro proliferation of NSCLC cells To testify that miR-451 may function as a tumor suppressor, the effects of miR-451 overexpression or downregulation on the proliferation of NSCLC cell were determined in vitro. Thereafter, a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) and colony formation assays were performed to detect the cell viability (Figure 5a ). SPC-A1 cells transfected with pre-miR-451 vector was observed to grow more slowly than those cells transfected control vector (Pre-miR-NC). In contrast, Anti-miR-451 could induce decreased viability of SPC-A1 cell. To further testify the antiproliferative effect of miR-451 on the growth of NSCLC cells, colony formation assay was performed. As shown in Figure 5b , the colony numbers of SPC-A1 cells stably transfected with pcDNA/miR-451 vector were significantly lower than those stably transfected with control pcDNA/miR-NC vector (Po0.01). Thus, the results of colony formation assay were consistent with those of MTT assay and further indicated that ectopic miR-451 expression could inhibit in vitro proliferation of NSCLC cells. Figure 6b ). Moreover, caspase-3 activity was significantly higher in cell extracts prepared from pcDNA/miR-451-transfected SPC-A1 cells than in pcDNA/miR-NC-transfected cells (Po0.01; Figure 6c ). These results suggested that ectopic expression of miR-451 could induce apoptosis enhancement in NSCLC cells in a caspase-3-dependent manner.
Effects of miR-451 expression on in vivo proliferation of NSCLC cells
To explore whether the level of miR-451 expression affect tumorigenesis, SPC-A1 cells transfected with pcDNA/miR-451 or anti-miR-451 were inoculated into MiR-451 directly targets RAB14 gene by interaction with the 3 0 -UTRs By performing a computational screen for genes with complementary sites of miR-451 in their 3 0 -UTR using open access softwares including TargetScan, miRBase targets and PicTarget, we found that Ras-related protein 14 (RAB14) was a putative target of miR-451. To confirm this possibility, the miR-451 binding sequences present at the 3 0 -UTR of RAB14 mRNA (WT-3 0 -UTR) or its mutant (MUT-3 0 -UTR) were subcloned into the downstream of the firefly luciferase reporter gene in pLUC vector ( Figure 8a ) and then co-transfected with pcDNA/miR-451 (or pcDNA/miR-NC) or anti-miR-451 (or anti-miR-NC) into HEK293T cells. The relative luciferase activity of the reporter that contained wildtype 3 0 -UTR was significantly decreased by 46.3% when pcDNA/miR-451 was co-transfected and it was significantly increased by 27.4% when anti-miR-451 was co-transfected (Po0.05), but the luciferase activity of 
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R Wang et al mutant reporter was unaffected by simultaneous transfection of pcDNA/miR-451 or anti-miR-451 (P40.05; Figure 8b ), suggesting that miR-451 might suppress RAB14 expression through miR-451-binding sequence at the 3 0 -UTR of RAB14. Next, whether miR-451 expression affects the expression of endogenous RAB14 at both transcriptional and translational levels was determined. As shown in Figure 8c , the levels of RAB14 mRNA showed no difference between pcDNA/miR-451-transfected SPC-A1 and pcDNA/miR-NC-transfected cells or between anti-miR-451-transfected SPC-A1 and anti-miR-NC-transfected cells (P40.05). However, western blot analysis showed that the level of RAB14 protein expression in pcDNA/miR-451-transfected SPC-A1 cells was significantly inhibited by 40.7% compared with that in pcDNA/miR-NC-transfected cells, while the level of RAB14 protein expression in anti-miR-451-transfected SPC-A1 cells was significantly upregulated by 42.4% compared with that in anti-miR-NC-transfected cells (Po0.05; Figure 8d ). These data indicated that miR-451 could directly target RAB14 in NSCLC cells by interaction with the 3 0 -UTRs of RAB14 gene.
Inhibition of RAB14 is potentially involved in the tumor suppressor function of miR-451
To investigate whether downregulation of RAB14 was involved in miR-451-induced growth suppression and apoptosis enhancement, we first analyzed whether siRNA-mediated RAB14 inhibition could recapitulate the tumor suppressor effect of miR-451 in NSCLC cell line. The expression levels of RAB14 mRNA and protein in siRNA/RAB14-transfected SPC-A1 cells were significantly reduced compared with siRNA/NC-transfected cells (Figure 9a ). Moreover, siRNA-mediated RAB14 knockdown could also significantly inhibit in vitro growth and colony formation of SPC-A1 cells (Po0.01; Figures 9b and c) . At the same time, siRNA/ RAB14 could significantly induce apoptosis enhancement in SPC-A1 cells (Po0.01; Figure 9d ). At 28 days, the average volume of tumors formed from siRNA/ RAB14-transfected SPC-A1 cells (368±48 mm 3 ) was significantly lower than that of tumors formed from siRNA/NC-transfected cells (587 ± 18 mm 3 ; Po0.05; Figure 9e ). Notably, the tumor suppressor effects of RAB14 knockdown mediated by siRNA were similar to those of ectopic miR-451 expression, suggesting that To further testify that RAB14 targeting was involved in miR-451-induced growth suppression and apoptosis enhancement, we then performed rescue experiments. In this study, we successfully constructed a plasmid vector (pEGFP-RAB14) expressing RAB14 gene, which could upregulate the expression of RAB14 protein in 16HBE cells with low RAB14 protein expression (Data not shown). Then, SPC-A1 cells were transfected with pcDNA/miR-451 for 24 h and followed by transfection with pEGFP-RAB14. We showed that co-transfection of pEGFP-RAB14 and pcDNA/miR-451 could rescue the decreased expression of RAB14 protein induced by ectopic miR-451 expression (Figure 10a) . Moreover, the co-transfection could partially rescue miR-451-promoted growth inhibition in SPC-A1 cells (Figure 10b ). In addition, the resulting RAB14 overexpression could also partially abrogate miR-451-promoted apoptosis enhancement (Figure 10c) . Furthermore, the tumors formed from SPC-A1 cells co-transfected with pcDNA/ miR-451 and pEGFP-RAB14 grew slowly compared with those formed from SPC-A1 cells transfected with pEGFP-RAB14 alone, but grew fast compared with those formed from SPC-A1 cells co-transfected with pcDNA/miR-451 and pEGFP-NC or transfected with pcDNA/miR-451 alone (Figure 10d) .
Meanwhile, SPC-A1 cells were transfected with anti-miR-451 for 24 h and followed by transfection with siRNA/RAB14. Results also showed that co-transfection of siRNA/RAB14 and anti-miR-451 could rescue the increased expression of RAB14 protein induced by the downregulated expression of miR-451 (Figure 11a) . Moreover, the co-transfection could partially rescue anti-miR-451-induced growth promotion and apoptosis inhibition in SPC-A1 cells (Figures 11b and c) . In addition, the tumors formed from SPC-A1 cells cotransfected with anti-miR-451 and siRNA/RAB14 grew slowly compared with those formed from SPC-A1 cells co-transfected with anti-miR-451 and siRNA/NC vector or transfected anti-miR-451 alone (Figure 11d ). Taken together, our results showed that restoration of RAB14 expression could partially rescue the tumor suppressor function of miR-451 in NSCLC cells, which further showed that RAB14 might be potentially involved in miR-451-regulated tumor suppressing function.
Effects of miR-451 on the survival pathways of NSCLC cells To further explore the mechanisms of miR-451-induced apoptosis enhancement, we analyzed the expression of apoptosis-related proteins in SPC-A1 cells after transfection with pcDNA/miR-451 or siRNA/RAB14 (Figure 12 ). The activation of caspase-3 could be observed in pcDNA/miR-451 or siRNA/RAB14-transfected SPC-A1 cells. To elucidate the upstream pathway leading to caspase-3 activation, western blot analysis was performed to detect the expression of bcl-2 protein family (Bcl-2, Bax and Bad). pcDNA/miR-451 or siRNA/RAB14 could lead to decreased levels of anti-apoptotic protein (Bcl-2) and increased levels of pro-apoptotic proteins (Bax and Bad). The Akt/Protein Kinase B signaling pathway is an important regulatory pathway governing the apoptotic response. Several studies have shown the importance of the Akt kinase signaling pathway, which is constitutively active in NSCLC and promotes cellular survival and resistance to chemotherapy and radiation (Brognard et al., 2001) . Thereafter, whether increasing miR-451 or decreasing RAB14 in SPC-A1 cells could specifically suppress Akt phosphorylation was also investigated. Results showed that pcDNA/miR-451 or siRNA/RAB14 transfection of the SPC-A1 cell line resulted in a marked reduction of phosphorylated Akt at Ser473 (Po0.05). In contrast, there was no significant change in the levels of total Akt protein after pcDNA/miR-451 or siRNA/RAB14 transfection. Thus, it was concluded that ectopic miR-451 expression or siRNA-mediated RAB14 inhibition could induce caspase-3-dependent apoptosis in NSCLC cells, which might be associated with inactivation of the Akt survival pathway.
The upregulation of RAB14 gene is detected in NSCLC tissue samples To address the biological significance of the RAB14-miR-451 interaction in NSCLC, immunohistochemistry was performed to detect the expression of RAB14 protien in NSCLC and corresponding non-tumor lung tissues. We showed that the immunostaining of RAB14 protein was mainly located in cytoplasm of normal epithelial or tumor cells ( Figure 13A ). All tumors showed positive immunostaining of RAB14 protein: 8 of 23 NSCLC cases (34.7%) showed weakly positive and the remainder (65.3%) showed strongly positive. In contrast, all of corresponding non-tumor lung tissues showed negative or weakly positive immunostaining of RAB14 protein. We also found that the stronger immunoreactivity of RAB14 was significantly associated with lower miR-451 expression (P ¼ 0.01; Figure 13B ). Therefore, higher expression of RAB14 protein was negatively associated with downregulated miR-451 in NSCLC tissue samples, suggesting that RAB14-miR-451 interaction might be biologically significant in human NSCLC.
Discussion
Although much remains to be learned, there is now emerging evidence suggesting that in addition to protein-encoding genes, miRNAs have more than a cursory role in the pathogenesis of human tumor development by functioning as agents of the RNA MicroRNA-451 functions as a tumor suppressor in human NSCLC R Wang et al interference pathway (Iorio and Croce, 2009 ). Up to now, the biological roles of only a small fraction of identified miRNAs have been elucidated. These miRNAs regulate cancer-related biological processes such as tumorigenesis, cell proliferation, angiogenesis and chemoresistance, and therefore, might themselves function as oncomirs or tumor suppressors (Baranwal and Alahari, 2010; Hummel et al., 2010) . Until recently, very few studies have been performed to determine the effects of miRNA and explore the molecular mechanisms by which miRNAs modulate the behavior of NSCLC cells in NSCLC.
In this study, we firstly determined the dysregulated expression profiles of miRNAs in NSCLC using miRNA arrays. We identified 27 miRNAs that are significantly upregulated and 13 miRNAs that are significantly downregulated in NSCLC tissues compared with corresponding non-tumor lung tissues. Although the tumor tissues were collected from different NSCLC patients, miRNA expression profiles were almost homogenous across all cases. The NSCLC miRNA expression profiles detected in our research were also nearly consistent with the results of previous NSCLC studies published by other groups. Specially, miR-451 was found to be the most downregulated miRNA in NSCLC. Previous studies have indicated that miR-451 was involved in the specific differentiation erythrocytes and the formation of basolateral polarity in epithelial cells (Masaki et al., 2007; Tsuchiya et al., 2009 ). In addition, miR-451 was upregulated significantly during the development of pulmonary arterial hypertension (Caruso et al., 2010) . Therefore, several human cell lines, including lung epithelial cells and erythrocytes, might require miR-451 for their maintenance and development (Williams et al., 2007) . Meanwhile, the relationships of miR-451 with other human cancers have been also reported. MiR-451 was found to be downregulated in childhood B-cell precursor acute lymphoblastic leukemia (Ju et al., 2009 ). Hui et al. reported that miR-451 was found to be the only significantly overexpressed miRNA by 4.7-fold between non-relapsed and relapsed patients with head and neck squamous cell carcinomas (Hui et al., 2010) . Moreover, the expression of miR-451 could affect biological functions of human tumor cells including proliferation, adaption to metabolic stress and sensitivity to chemo or radiotherapy. Bandres et al. showed that overexpression of miR-451 in gastric and colorectal cancer cells reduced cell proliferation and increased sensitivity to radiotherapy by regulating macrophage migration-inhibitory factor production (Bandres et al., 2009) . It was also shown that miR-451 was involved in resistance of the MCF-7 breast cancer MicroRNA-451 functions as a tumor suppressor in human NSCLC R Wang et al cells to chemotherapeutic drug doxorubicin and differentiation of glioblastoma stem cells to CD133-cells (Gal et al., 2008; Kovalchuk et al., 2008) . Furthermore, miR-451 combined with miR-27a function as activators of MDR1/P-gp expression, suggesting that approach to targeting these two miRNAs may offer novel therapeutic opportunities for the treatment of MDR cancers (Zhu et al., 2008) . Although these results show that miR-451 may have vital roles in tumor progression, its roles in human NSCLC remains to be elucidated. In this study, we analyzed the clinicopathological significance of miR-451 expression in NSCLC. The average expression level of miR-451 in NSCLC tissues was significantly higher than that in corresponding non-tumor lung tissues. The relative expression level of miR-451 in NSCLC patients was associated with tumor differentiation, pathological stage and the status of lymph-node metastasis. Moreover, the lower level of miR-451 expression might be correlated with a poorer survival of NSCLC patients. As the small size of tissue samples in this study was limited, further investigation of a larger patient population is necessary to confirm its clinical significance and prognostic evaluation in NSCLC. In addition, the level of miR-451 expression in NSCLC cell lines could be observed to be significantly lower than that in normal human bronchial epithelial cell line. We also found that miR-451 was significantly upregulated when SPC-A1 cell line was treated with 
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R Wang et al 5-aza-dC or PB. miR-451 is located in human chromosome 17, which is a submetacentric chromosome containing 2.6% of the genetic material in the genome and has a large number of CpG islands (Makos et al., 1992) . Thus, it was concluded that epigenetic silencing by DNA methylation or histone deacetylation might be involved in downregulation of miR-451 in NSCLC, which is being further explored by other members of our research group. This study is the first to show that miR-451 functions as tumor suppressor and regulates survival in NSCLC cells. It is also the first study to show that oncogene Ras-related protein (RAB14) is negatively regulated by miR-451 at the posttranscriptional level via binding to 3 0 -UTR of RAB14 mRNA in NSCLC cells. In our study, the level of miR-451 expression could significantly affect growth of NSCLC cells both in vitro and in vivo, and the growth inhibition induced by ectopic miR-451 overexpression might be associated with caspase-3-dependent apoptosis enhancement Meanwhile, our findings showed that overexpression of miR-451 in NSCLC cells led to decreased phosphorylation of AKT and increased BAX or Bad protein levels, which finally induced activation of caspase-3. Identification of target genes regulated by miRNAs will be helpful to highlight the functions of miRNA in various life processes. Many studies have clearly indicated that one miRNA could control multiple genes, whereas one gene could also be regulated by multiple miRNAs (Yousef, 2008; Peter, 2010) . Through bioinformation analysis, we found that RAB14 might be also one of target genes of miR-451. At the same time, we also found that exogenous miR-451 could downregulate the expression of RAB14 protein in NSCLC cells. Moreover, the luciferase assay with a reporter containing the wild miR-451 binding sequence at the 3 0 -UTR of RAB14 mRNA indicated that the luciferase activity could be significantly reduced or upregulated by overexpression or downregulation of miR-451. Of course, RAB14 might be regulated by other miRNAs and further studies will be needed to clarify this point.
RAB14 is a member RAS oncogene family of small GTPase, which contains over 170 members, divided into five subfamilies-RAS, RHO, RAB, RAN and ARF (Takai et al., 2001) . Among these small G proteins, the Ras subfamily is the most studied for its critical roles in human oncogenesis (Cheng et al., 2005) . RAB proteins have been reported to have vital roles in vesicle trafficking, signal transduction and receptor recycling, which in turn regulate normal cellular activity (Rosenfeld et al., 2002; Kardassis et al., 2009) . Therefore, RAB dysfunction might be involved in human cancers and other diseases. Recently, a member of the RAS superfamily RAB25 has also been implicated in human cancers (Agarwal et al., 2009) , but there have no reports about the association of RAB14 with human cancers. Moreover, Zhang et al. have identified RAB14 protein as a possible tumor marker of lung cancer by using twodimensional gel electrophoresis and matrix-assisted laser desorption ionization time of flight mass spectrometry, but the roles of RBA14 protein in lung cancer remain unclear (Zhang et al., 2009) . Thereafter, we inhibited RAB14 expression by RNA interference and found that the inhibition of RAB14 could significantly inhibit proliferation and induce caspase-3-dependent apoptosis enhancement. In addition, RNAi targeting RAB14 could also decrease phosphorylation of AKT, which induced the decreased levels of Bcl-2 protein expression and the increased levels of BAX or Bad protein expression. These results were similar to the effects of ectopic miR-451 expression in NSCLC cells. At the same time, RAB14 overexpression or downregulation could partially block the effects induced by ectopic overexpression or blockade of miR-451 in NSCLC cells. Furthermore, the expression levels of RAB14 protein were inversely correlated with the expression levels of miR-451 in NSCLC tissues. Thus, it was concluded that downregulation of RAB14 might be a mechanism by which miR-451 exerts its tumor suppressor functions.
In summary, we have reported the altered miRNA expression pattern in NSCLC and shown that miR-451 functions as a tumor suppressor in NSCLC by targeting RBA14. Our experimental data may provide a strategy for targeting with the miR-451/RAB14 interaction as a novel therapeutic application to treat NSCLC patients.
Materials and methods
Ethics statement
All experimental procedures were approved by the Institutional Review Board of Jiangsu Province Medical Association. Written informed consent was obtained for all patient samples. Animal experiments were performed with the approval of the Institutional Committee for Animal Research and in conformity with national guidelines for the care and use of laboratory animals.
Tissue samples A total of 23 patients who were diagnosed as primary NSCLC in the Department of Cardiothoracic Surgery of Nanjing Chest Hospital from 2006 to 2008 were included in this study. None of these patients received chemotherapy and radiotherapy before the surgery. The clinicopathological factors of the patients were summarized in Supplementary Table S2 . Tumor and corresponding non-tumor lung tissue samples were collected and rapidly frozen in liquid nitrogen and stored at À80 1C. Ethical approval was obtained from the hospital and fully informed consent from all patients before sample collection.
Cell culture Three NSCLC cell lines (A549, SPC-A1 and NCI-H520), a normal human bronchial epithelial cell line (16HBE) and a human embryonic kidney cell line (HEK293T) were cultured in RPMI 1640 (GIBCO-BRL) medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 mg/ml streptomycin in humidified air at 37 1C with 5% CO 2 .
RNA extraction from tissues
The fresh tissues were then washed in buffer for 30 min, and were digested to obtain a single-cell suspension by using trypsogen. After centrifugation at 500 Â g for 10 min 4 1C, the supernate was removed. Then, Erythrocyte Lysing Solution (ELS) (Sai Chi Bio-Science Ltd, Beijing, China) was added into the sediment cells according to protocol. After centrifugation at 1000 Â g for 5 min at 4 1C, the red superstratum clear liquid was removed. The sediment was collected and washed twice with phosphate-buffered saline. Finally, the sediment cells were suspended with phosphate-buffered saline and used for RNA extraction with TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions.
MicroRNA microarray
Total RNA was isolated using above methods and the quality and quantity of the RNA samples were assessed by standard electrophoresis and spectrophotometer methods. miRNA microarray analysis was performed by LC Sciences (Houston, TX, USA). Microarrays used mParaflo microfluidic chip technology (Atactic Technologies, Houston, TX, USA) and optimized RNA hybridization probes with a detection limit of o100 attomole that was cross referenced to the Sanger miRNA database (Release 10.0, http://microrna.sanger.ac.uk/) after normalization. The data from the microarray was collected and analyzed in accordance to the MIAME guidelines.
Bioinformatics methods
The miRNA targets predicted by computer-aided algorithms were obtained from pictar (http://pictar.mdc-berlin.de/cgi-bin/ new_PicTar_vertebrate.cgi.), targetscan (http://www.targetscan. org) and mirbase targets (http://microrna.sanger.ac.uk/cgi-bin/ targets/v5/search.pl).
Treatment of cells with 5-aza-2
0 -deoxycytidine (5-aza-dC) and sodium phenylbutyrate (PB) SPC-A1 cells (4.0 Â 10 4 ) were seeded into six-well culture plate on day 0 and exposed to 10 mmol/l 5-aza-2 0 -deoxycytidine (5-aza-dC) and/or 3 mmol/l sodium phenylbutyrate (PB) for day 1 to day 3. Thereafter, the cells treated with 5-aza-dC, PB, or both were harvested on day 3 and used for detection of miR-451 expression.
TaqMan real-time PCR-TaqMan miRNA analysis of mature miR-451 expression used the stem-loop method For RT reactions, 10 ng of total RNA was used in each reaction (15 ml) and mixed with the RT primer (3 ml). The RT primers were designed as follows: miR-451, 5 0 -CTCAACTGG TGTCGTGGAGTCGGCAATTCAGTTGAGAAACTCAG-3 0 and U6, 5 0 -TGGTGTCGTGGAGTCG-3 0 . The RT reaction was carried out under the following conditions: 16 1C for 30 min; 42 1C for 30 min; 85 1C for 5 min; and then held on 4 1C. After the RT reaction, the complementary DNA products were diluted at 150 Â , and 1.33 ml of the diluted complementary DNA was used for PCR reaction along with TaqMan primers (2 ml). The PCR primers for mature miR-451 or U6 were designed as follows: miR-451 sense, 5 0 -ACACTCC AGCTGGGAAACCGTTACCATTACT-3 0 and reverse, 5 0 -C TGGTGTCGTGGAGTCGGCAA-3 0 ; U6 sense, 5 0 -CTCGCT TCGGCAGCACA-3 0 and reverse, 5 0 -AACGCTTCACGAAT TTGCGT-3 0 . The PCR reaction was conducted at 95 1C for 10 min followed by 40 cycles of 95 1C for 15 s and 60 1C for 60 s in the ABI 7500 real-time PCR system (Applied Biosystems, Foster City, CA, USA). The real-time PCR results were analyzed and expressed as relative miRNA expression of CT (threshold cycle) value, which was then converted to fold changes. The RT primer, PCR primers, and TaqMan probe for miR-451 were purchased from ABI. U6 was used for normalization.
Conventional RT-PCR analysis of RAB14 mRNA expression Total RNA was extracted from cells and was reverse transcribed using RT-PCR kits (Applied Biosystems) with an oligo d(T)16 primer under standard conditions. RAB14-specific primers were designed as follows: 5 0 -CGCTCGAGAT GGCAACTGCACCATACAAC-3 0 and reverse, 5 0 -CGGAAT TCCTAGCAGCCACAGCCTTCTC-3 0 . To verify integrity of RAB14 expression, GAPDH gene was used as an internal control and the sequences of primers were as follows: sense, 5 0 -GGAGTCAACGGATTTGGTCG-3 0 and reverse, 5 0 -CAT CGCCCCACTTGATTTTG-3 0 . PCR conditions were 30 cycles consisted of denaturation at 94 1C for 30 s, annealing at 56 1C (58 1C for GAPDH) for 30 s, and extension at 72 1C for 30 s. Each PCR product was separated by 1.5% agarose gel electrophoresis and visualized by ethidium bromide staining.
Western blot assay
Cell protein lysates were separated in 10% sodium dodecyl sulfate polyacrylamide gels, electrophoretically transferred to polyvinylidene difluoride membranes (Roche Diagnostics, Mannheim, Germany), then detected with anti-cleaved caspase-3, RAB14, phosphorylated Akt (473), total Akt, Bad and Bax proteins. Protein loading was estimated using mouse anti-GAPDH monoclonal antibody. Lab Works Image Acquisition and Analysis Software (UVP, Upland, CA, USA) were used to quantify band intensities. Antibodies were purchased from Univ-bio Inc (Shanghai, China).
Plasmid constructs
A DNA fragment containing the hsa-miR-451 locus situated at chromosome 17 (17q11.2) plus 250 bp upstream and downstream from the 72 bp miR-451 precursor was amplified from 16HBE cell genomic DNA and cloned into pcDNA( þ )3.1 (Invitrogen). The successfully plasmid vector expressing precursor miR-451 was named pcDNA/miR-451. To ectopically express RAB14, the RAB14-coding region was subcloned into pEGFP-N3 vector (Invitrogen) by PCR method using the following primers: sense, 5 0 -CGCTCGAGATGGCAACTGC ACCATACAAC-3 0 ; reverse, 5 0 -CGGAATTCCTAGCAGCC ACAGCCTTCTC-3 0 . To construct a luciferase reporter vector, RAB14 3 0 -UTR fragment containing putative binding sites for miR-451 was amplified by PCR using the following primers: sense-5 0 -CGCTCGAGTTTATTGCAGCACTGTCC ATATTCA-3 0 and reverse-5 0 -GCGGATCCCTGTTTGGAA TAAAAACCTTGGTG-3 0 and cloned downstream of the luciferase gene in the pLUC Luciferase vector (Ambion, Inc., Austin, TX, USA) and named RAB14 3 0 -UTR-WT. Sitedirected mutagenesis of the miR-451 target site in the RAB14-3 0 -UTR was performed using the Quick-change mutagenesis kit (Stratagene, Heidelberg, Germany) and named RAB14 3 0 -UTR-Mut, in which 3 0 -UTR-WT was used as a template. For the mutated construct, the miR-451 target site 5 0 -TTGGCAAT-3 0 was substituted with a 5 0 -CCAAAGGC-3 0 fragment.
Transfection of cell lines
All plasmid vectors (pcDNA/miR-451 and pcDNA/miR-NC used as a negative control) for transfection were extracted by DNA Midiprep or Midiprep kit (Qiagen, Hilden, Germany). Anti-miR-451 inhibitor (5 0 -UCAACAUCAGUCUGAUAAG CUA-3 0 ) and mismatched sequence negative control oligonucleotide (50-CAGUACUUUUGUGUAGUACAA-30) were synthesized by GenePharma, Shanghai, China. RAB14-siRNA (sc-76313) named siRNA/RAB14 and non-specific control siRNA (siRNA/NC) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). SPC-A1 cells were grown on six-well plate to confluence and transfected using Lipofectamine2000 (Invitrogen) according to the manufacturer's instruction.
Assay of luciferase activity
Human HEK293T cells grown in a 48-well plate were co-transfected with 200 ng of either mock pcDNA/miR-NC or pcDNA/miR-195 vector, 10 ng of firefly luciferase reporter comprising wild type or mutant 3 0 -UTR of RAB14 gene, and 2 ng of pRL-TK (Promega, Madison, WI, USA). The luciferase assay was performed as previously described (Xu et al., 2009) .
Cell proliferation assay
At 72 h after transfection, SPC-A1 or A549 cell were cultured in 96-well plates and were harvested for a standard tetrazolium bromide (MTT) assay as previously described (Guo et al., 2008) . All assays were performed in Octuplicate and repeated at least three times.
Colony formation assay A total of 1500 pcDNA/miR-NC or pcDNA/miR-195-transfected SPC-A1 or A549 cells were placed in a fresh six-well plate and maintained in DMEM containing 10% fetal bovine serum. After 24 h, the medium was replaced with new medium containing G418 (400 mg/ml). After 14 days, cells were fixed with methanol and stained with 0.1% crystal violet. Visible colonies were manually counted.
Flow-cytometric analysis of cell cycle Cells were collected and fixed. After incubation in RNase A (1 mg/ml) for 30 min at 37 1C, the cells were stained with propidium iodide (50 mg/ml). Flow-cytometric analysis was done using a FACScan instrument (Becton Dickinson, Mountain view, CA, USA) and CellQuest software (Becton Dickinson, San Jose, CA, USA), as previously reported .
Flow-cytometric analysis of apoptosis An annexin V-fluorescein isothiocyanate (FITC) apoptosis detection kit (Oncogene Research Products, Boston, MA, USA) was used to detect apoptosis as previously described (Yang et al., 2000) . All of the samples were assayed in triplicate.
Hoechst staining assay Cells were cultured on six-well tissue culture plates to confluence, and Hoechst 33342 (Sigma, St Louis, MO, USA) was added to the culture medium of living cells; changes in nuclear morphology were detected by fluorescence microscopy using a filter for Hoechst 33342 (365 nm). For quantification of Hoechst 33342 stainings, the percentages of Hoechst-positive nuclei per optical field (at least 50 fields) were counted.
Analysis of caspase-3 activity Caspase-3 activity was determined using the colorimetric CaspACE Assay System (Promega Corp) following the manufacturer's instructions, as previously reported (Yokoi et al., 2003) . Each determination was performed in triplicate.
Immunohistochemistry Paraffin-embedded, formalin-fixed tissues were immunostained for RAB14 and PCNA proteins as previously described (Hu et al., 2005) .
In vivo studies Animal studies were performed according to institutional guidelines. pcDNA/miR-451 (or siRNA/RAB14)-and pcDNA/ miR-NC (or siRNA/control)-transfected SPC-A1 or A549 cells (5.0 Â 10 6 ) were suspended in 100 ml phosphate-buffered saline and then injected subcutaneously into either side of the posterior flank of the same female BALB/c athymic nude mouse (Charles River Breeding Laboratories, Wilmington, MA, USA) at 5-6 weeks of age. Tumor growth was examined weekly for at least 5 weeks. After 35 days, the mice were killed, necropsies were performed, and tumors were weighted. Tumor volumes were calculated by using the equation V (in mm
/2, where A is the largest diameter, and B is the perpendicular diameter. The primary tumors were excised and tumor tissues were used to perform immunostaining analysis of PCNA protein expression.
Statistical analyses
The SPSS10.0 program was used for general statistical and survival analysis. Experimental data were expressed as the mean ± s.e.m. The differences between groups were analyzed using Student's t-test when only two groups, or assessed by one-way analysis of variance (ANOVA) when more than two groups were compared. All tests performed were two sided. Differences were considered statistically significant at Po0.05.
